Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

October 14, 2013

Primary Completion Date

April 13, 2016

Study Completion Date

September 19, 2016

Conditions
Carcinoma, Squamous Cell of Head and Neck
Interventions
DRUG

VTX-2337

TLR8 Agonist

DRUG

Carboplatin

DRUG

Cisplatin

DRUG

5-fluorouracil

DRUG

Placebo

Trial Locations (53)

10016

The Bellevue Hospital, New York

10029

Mount Sinai Medical Center, New York

11042

Monter Cancer Center, Lake Success

11794

Stony Brook University Medical Center, Stony Brook

15232

University of Pittsburgh Cancer Institute, Pittsburgh

17033

Pennsylvania State Hershey Cancer Institute, Hershey

18045

Saint Lukes Cancer Centre, Easton

19713

Helen F. Graham Cancer Center, Newark

20889

Walter Reed National Military Medical Center, Bethesda

21231

The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore

22031

Virginia Cancer Specialists, PD, Fairfax

27103

Wake Forest University Baptist Medical Center, Winston-Salem

27599

University of North Carolina at Chapel Hill, Chapel Hill

29425

Hollings Cancer Center, Charleston

30322

Winship Cancer Institute, Atlanta

30607

Northeast Georgia Cancer Care, LLC, Athens

32806

MD Anderson Cancer Center, Orlando

38120

The West Clinic, Memphis

44106

University Hospitals of Cleveland, Cleveland

44195

Cleveland Clinic, Cleveland

48075

Providence Cancer Institute, Southfield

48201

Karmanos Cancer Institute, Detroit

48202

Henry Ford Health System, Detroit

53226

Medical College of Wisconsin, Milwaukee

Aurora Advanced Healthcare, Inc., Wauwatosa

60611

Northwestern University Feinberg School of Medicine, Chicago

61801

Carle Cancer Center, Urbana

63044

Saint Louis Cancer Care, LLP, Bridgeton

63110

Barnes Jewish Hospital, St Louis

66205

University of Kansas Cancer Center, Westwood

70072

Crescent City Research Consortium, LLC, Marrero

72205

University of Arkansas for Medical Sciences, Little Rock

78234

San Antonio Military Medical Center, Fort Sam Houston

80045

University of Colorado Cancer Center, Aurora

80220

VA Eastern Colorado Healthcare System, Denver

89106

Nevada Cancer Research Foundation, Las Vegas

90033

University of California Norris Comprehensive Cancer Center, Los Angeles

90211

Tower Hematology Oncology Medical Group, Beverly Hills

92025

California Cancer Associates for Research and Excellence (CCARE), Escondido

92093

University of California San Diego Moores Cancer Center, La Jolla

96859

Tripler Army Medical Center, Honolulu

97213

Providence Cancer Center, Portland

97701

Saint Charles Medical Center, Bend

98431

Madigan Army Medical Center, Tacoma

99208

Medical Oncology Associates, PS, Spokane

70006-2936

Robert W. Veith, MD, LLC, Metairie

04074

Maine Center for Cancer Medicine, Scarborough

02215

Dana Farber Cancer Institute, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

07834

Oncology and Hematology Specialists, P.A., Denville

07601

Hackensack University Medical Center, Hackensack

45267-0502

University of Cincinnati, Cincinnati

75390-8852

University of Texas Southwestern Medical Center at Dallas, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY